WGS
GeneDx Holdings Corp. · Healthcare · Medical - Diagnostics & Research
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +10.5% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 88 | -5 | 15.43M | $1.06B | +10 | −14 |
| Q1 2026 | 95 | +2 | 15.21M | $977.50M | +14 | −13 |
| Q4 2025 | 94 | +1 | 15.07M | $1.96B | +3 | −1 |
| Q3 2025 | 16 | -1 | 7.41M | $798.15M | +2 | −4 |
| Q2 2025 | 15 | -1 | 4.67M | $430.80M | +1 | −2 |
| Q1 2025 | 13 | 0 | 2.11M | $186.46M | — | — |
| Q4 2024 | 13 | +1 | 1.90M | $146.41M | +2 | −1 |
| Q3 2024 | 11 | +4 | 1.69M | $71.81M | +4 | — |
| Q2 2024 | 7 | — | 992.14K | $25.94M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 425.65K | +202.3% | $37.70M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Wellington Management ✦ | 425.65K | +202.3% | $37.70M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Wellington Management ✦ | 425.65K | +202.3% | $37.70M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 425.65K | +202.3% | $37.70M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | D. E. Shaw & Co. ✦ | 399.70K | +35.7% | $35.40M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | D. E. Shaw & Co. ✦ | 399.70K | +35.7% | $35.40M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Geode Capital Management ✦ (passive) | 392.73K | +2.7% | $34.79M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | Geode Capital Management ✦ (passive) | 392.73K | +2.7% | $34.79M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | State Street Global Advisors ✦ (passive) | 339.63K | +6.2% | $30.08M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Point72 Asset Management ✦ | 286.97K | +354.9% | $25.42M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 11 | Renaissance Technologies ✦ | 70.22K | -65.8% | $6.22M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 12 | Norges Bank ✦ (passive) | 68.00K | 0.0% | $6.02M | 0.0% | Held | 2 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 28.40K | -64.1% | $2.51M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 14 | Two Sigma Investments ✦ | 28.36K | -81.3% | $2.51M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 25.06K | -56.4% | $2.22M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 25.06K | -56.4% | $2.22M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 25.06K | -56.4% | $2.22M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 25.06K | -56.4% | $2.22M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | Millennium Management ✦ | 15.78K | -73.2% | $1.40M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 20 | Gotham Asset Management ✦ | 13.77K | -17.0% | $1.22M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | T. Rowe Price ✦ | 11.02K | -83.5% | $977,000 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 22 | T. Rowe Price ✦ | 11.02K | -83.5% | $977,000 | 0.0% | ▼ Trim | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 28.70K shares, $1,843 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.